This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

3 Mar 2020

Thermo Fisher Scientific to acquire Qiagen

Thermo Fisher Scientific said Tuesday it has agreed to buy Dutch molecular testing and diagnostics specialist Qiagen for €39 per share in cash, valuing the overall transaction at around USD 11.5 billion.

According to Thermo, the acquisition will bring together the companies’ complementary offerings thereby advancing Thermo’s customers’ work, from discovery to diagnostics.

Specifically, the transaction will expand Thermo's specialty diagnostics portfolio with molecular diagnostics capabilities, including infectious disease testing.

Qiagen, which employs around 5,100 people at 35 locations in more than 25 countries, provides sample preparation technologies to extract, isolate and purify DNA, RNA and proteins from a wide range of biological samples.

The company's assay technologies are then used to amplify and enrich these biomolecules to make them readily accessible for analysis. In addition, the company's instruments can be used to automate these workflows, whereas its bioinformatics systems provide customers with relevant, actionable insights.

"This acquisition provides us with the opportunity to leverage our industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific.

"This strategic step with Thermo Fisher ... is designed to deliver significant cash value to our shareholders, while enabling us to accelerate the expansion of our solutions to provide customers worldwide with breakthroughs that advance our knowledge about the science of life and improve health outcomes," said Thierry Bernard, interim chief executive officer of Qiagen and senior vice president, head of the molecular diagnostics business area.

Mentioned Companies
Thermo Fisher Scientific Inc.
View company profile

Related News